Novavax (LTS:0UP6) Accounts Payable : $58 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Novavax Accounts Payable?

Novavax's Accounts Payable for the quarter that ended in Mar. 2024 was $58 Mil.

Novavax's quarterly Accounts Payable increased from Sep. 2023 ($102 Mil) to Dec. 2023 ($133 Mil) but then declined from Dec. 2023 ($133 Mil) to Mar. 2024 ($58 Mil).

Novavax's annual Accounts Payable increased from Dec. 2021 ($127 Mil) to Dec. 2022 ($217 Mil) but then declined from Dec. 2022 ($217 Mil) to Dec. 2023 ($133 Mil).

Novavax Accounts Payable Historical Data

The historical data trend for Novavax's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novavax Accounts Payable Chart

Novavax Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

2.91

54.33

127.05

216.52

132.61

Novavax Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															124.80	87.25	101.91	132.61	57.72

Novavax Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Novavax Accounts Payable Related Terms

Thank you for viewing the detailed overview of Novavax's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Novavax (LTS:0UP6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novavax Inc (LTS:0UP6) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

NVAX:USA NVAX:Mexico NVV1:Germany

Address

21 Firstfield Road, Gaithersburg, MD, USA, 20878

Website

https://www.novavax.com

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.

Novavax (LTS:0UP6) Headlines

No Headlines